CLOVER HEALTH INVESTMENTS CO's ticker is CLOV and the CUSIP is 18914F103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70 | +22.8% | 65,233 | +2.5% | 0.00% | – |
| Q2 2023 | $57 | -71.4% | 63,644 | -73.1% | 0.00% | – |
| Q1 2023 | $199 | +38.2% | 236,256 | +52.8% | 0.00% | – |
| Q4 2022 | $144 | -99.9% | 154,638 | +129.8% | 0.00% | – |
| Q3 2022 | $115,000 | 0.0% | 67,289 | +25.2% | 0.00% | – |
| Q2 2022 | $115,000 | +1542.9% | 53,734 | +2534.0% | 0.00% | – |
| Q1 2022 | $7,000 | – | 2,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Structured Capital Management Ltd. | 1,973,944 | $7,008,000 | 16.49% |
| Lee Financial Group Hawaii, Inc. | 85 | $24,000,000 | 16.36% |
| Summit Rock Advisors, LP | 210,639 | $748,000 | 0.46% |
| CTC Capital Management, LLC | 30,800 | $109,000 | 0.29% |
| SAGE RHINO CAPITAL LLC | 261,500 | $928,000 | 0.28% |
| University of Massachusetts Foundation, Inc. | 70,049 | $249,000 | 0.23% |
| EQUITEC PROPRIETARY MARKETS, LLC | 161,757 | $574,000 | 0.13% |
| Gainplan LLC | 45,767 | $162,000 | 0.12% |
| Bayesian Capital Management, LP | 211,500 | $751,000 | 0.11% |
| Perceptive Advisors | 1,500,000 | $5,325,000 | 0.11% |